 | • レポートコード：D005-15813 • 出版社/出版日：GlobalInfoResearch / 2020年5月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、経皮的神経刺激装置の世界市場を広く調査・分析し、今後の市場展望をまとめております。経皮的神経刺激装置の種類別市場規模（仙骨神経、迷走神経、脳、その他）、用途別市場規模（アルツハイマー病、胃不全麻痺、失禁、パーキンソン病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Medtronic、ReShape Lifesciences、Boston Scientific Corporation、Apnex Medical、Dynatronics Corporation、BioMedical Life Systems、Abbott、DJO、Cochlear LTD、MED-EL Corporation ・地域別グローバル市場分析 2015年-2020年 ・経皮的神経刺激装置の北米市場（アメリカ、カナダ、メキシコ） ・経皮的神経刺激装置のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・経皮的神経刺激装置のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・経皮的神経刺激装置の南米市場（ブラジル、アルゼンチン） ・経皮的神経刺激装置の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：仙骨神経、迷走神経、脳、その他 ・用途別分析：アルツハイマー病、胃不全麻痺、失禁、パーキンソン病、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Transcutaneous Neurostimulator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Transcutaneous Neurostimulator market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Transcutaneous Neurostimulator market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Transcutaneous Neurostimulator market has been segmented into
Sacral Nerves
Vagus Nerves
Brain
Others
By Application, Transcutaneous Neurostimulator has been segmented into:
Alzheimer’s Disease
Gastroparesis
Incontinence
Parkinson’s Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Transcutaneous Neurostimulator market presented in the report. This section sheds light on the sales growth of different regional and country-level Transcutaneous Neurostimulator markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Transcutaneous Neurostimulator market.
The report offers in-depth assessment of the growth and other aspects of the Transcutaneous Neurostimulator market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Transcutaneous Neurostimulator Market Share Analysis
Transcutaneous Neurostimulator competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Transcutaneous Neurostimulator sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Transcutaneous Neurostimulator sales, revenue and market share for each player covered in this report.
The major players covered in Transcutaneous Neurostimulator are:
Medtronic
ReShape Lifesciences
Boston Scientific Corporation
Apnex Medical
Dynatronics Corporation
BioMedical Life Systems
Abbott
DJO
Cochlear LTD
MED-EL Corporation
Among other players domestic and global, Transcutaneous Neurostimulator market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transcutaneous Neurostimulator product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transcutaneous Neurostimulator, with price, sales, revenue and global market share of Transcutaneous Neurostimulator in 2018 and 2019.
Chapter 3, the Transcutaneous Neurostimulator competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transcutaneous Neurostimulator breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Transcutaneous Neurostimulator market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Transcutaneous Neurostimulator sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Transcutaneous Neurostimulator Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transcutaneous Neurostimulator Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Sacral Nerves
1.2.3 Vagus Nerves
1.2.4 Brain
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Transcutaneous Neurostimulator Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Alzheimer’s Disease
1.3.3 Gastroparesis
1.3.4 Incontinence
1.3.5 Parkinson’s Disease
1.3.6 Others
1.4 Overview of Global Transcutaneous Neurostimulator Market
1.4.1 Global Transcutaneous Neurostimulator Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 ReShape Lifesciences
2.2.1 ReShape Lifesciences Details
2.2.2 ReShape Lifesciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ReShape Lifesciences SWOT Analysis
2.2.4 ReShape Lifesciences Product and Services
2.2.5 ReShape Lifesciences Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boston Scientific Corporation
2.3.1 Boston Scientific Corporation Details
2.3.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boston Scientific Corporation SWOT Analysis
2.3.4 Boston Scientific Corporation Product and Services
2.3.5 Boston Scientific Corporation Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Apnex Medical
2.4.1 Apnex Medical Details
2.4.2 Apnex Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Apnex Medical SWOT Analysis
2.4.4 Apnex Medical Product and Services
2.4.5 Apnex Medical Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Dynatronics Corporation
2.5.1 Dynatronics Corporation Details
2.5.2 Dynatronics Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Dynatronics Corporation SWOT Analysis
2.5.4 Dynatronics Corporation Product and Services
2.5.5 Dynatronics Corporation Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 BioMedical Life Systems
2.6.1 BioMedical Life Systems Details
2.6.2 BioMedical Life Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BioMedical Life Systems SWOT Analysis
2.6.4 BioMedical Life Systems Product and Services
2.6.5 BioMedical Life Systems Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abbott SWOT Analysis
2.7.4 Abbott Product and Services
2.7.5 Abbott Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 DJO
2.8.1 DJO Details
2.8.2 DJO Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 DJO SWOT Analysis
2.8.4 DJO Product and Services
2.8.5 DJO Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cochlear LTD
2.9.1 Cochlear LTD Details
2.9.2 Cochlear LTD Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cochlear LTD SWOT Analysis
2.9.4 Cochlear LTD Product and Services
2.9.5 Cochlear LTD Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 MED-EL Corporation
2.10.1 MED-EL Corporation Details
2.10.2 MED-EL Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 MED-EL Corporation SWOT Analysis
2.10.4 MED-EL Corporation Product and Services
2.10.5 MED-EL Corporation Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Transcutaneous Neurostimulator Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Transcutaneous Neurostimulator Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Transcutaneous Neurostimulator Manufacturer Market Share in 2019
3.3.2 Top 6 Transcutaneous Neurostimulator Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Transcutaneous Neurostimulator Sales, Revenue and Market Share by Regions
4.1.1 Global Transcutaneous Neurostimulator Sales and Market Share by Regions (2015-2020)
4.1.2 Global Transcutaneous Neurostimulator Revenue and Market Share by Regions (2015-2020)
4.2 North America Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
4.3 Europe Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
4.5 South America Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Transcutaneous Neurostimulator Sales, Revenue and Market Share by Country
5.1.1 North America Transcutaneous Neurostimulator Sales and Market Share by Country (2015-2020)
5.1.2 North America Transcutaneous Neurostimulator Revenue and Market Share by Country (2015-2020)
5.2 United States Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
5.3 Canada Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
5.4 Mexico Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Transcutaneous Neurostimulator Sales, Revenue and Market Share by Country
6.1.1 Europe Transcutaneous Neurostimulator Sales and Market Share by Country (2015-2020)
6.1.2 Europe Transcutaneous Neurostimulator Revenue and Market Share by Country (2015-2020)
6.2 Germany Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
6.3 UK Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
6.4 France Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
6.5 Russia Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
6.6 Italy Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Transcutaneous Neurostimulator Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Transcutaneous Neurostimulator Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Transcutaneous Neurostimulator Revenue and Market Share by Regions (2015-2020)
7.2 China Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
7.3 Japan Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
7.4 Korea Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
7.5 India Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
7.7 Australia Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Transcutaneous Neurostimulator Sales, Revenue and Market Share by Country
8.1.1 South America Transcutaneous Neurostimulator Sales and Market Share by Country (2015-2020)
8.1.2 South America Transcutaneous Neurostimulator Revenue and Market Share by Country (2015-2020)
8.2 Brazil Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
8.3 Argentina Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Transcutaneous Neurostimulator Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Transcutaneous Neurostimulator Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Transcutaneous Neurostimulator Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
9.3 Turkey Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
9.4 Egypt Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
9.5 South Africa Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Transcutaneous Neurostimulator Sales and Market Share by Type (2015-2020)
10.2 Global Transcutaneous Neurostimulator Revenue and Market Share by Type (2015-2020)
10.3 Global Transcutaneous Neurostimulator Price by Type (2015-2020)
11 Global Transcutaneous Neurostimulator Market Segment by Application
11.1 Global Transcutaneous Neurostimulator Sales Market Share by Application (2015-2020)
11.2 Global Transcutaneous Neurostimulator Revenue Market Share by Application (2015-2020)
11.3 Global Transcutaneous Neurostimulator Price by Application (2015-2020)
12 Market Forecast
12.1 Global Transcutaneous Neurostimulator Sales, Revenue and Growth Rate (2021-2025)
12.2 Transcutaneous Neurostimulator Market Forecast by Regions (2021-2025)
12.2.1 North America Transcutaneous Neurostimulator Market Forecast (2021-2025)
12.2.2 Europe Transcutaneous Neurostimulator Market Forecast (2021-2025)
12.2.3 Asia-Pacific Transcutaneous Neurostimulator Market Forecast (2021-2025)
12.2.4 South America Transcutaneous Neurostimulator Market Forecast (2021-2025)
12.2.5 Middle East & Africa Transcutaneous Neurostimulator Market Forecast (2021-2025)
12.3 Transcutaneous Neurostimulator Market Forecast by Type (2021-2025)
12.3.1 Global Transcutaneous Neurostimulator Sales Forecast by Type (2021-2025)
12.3.2 Global Transcutaneous Neurostimulator Market Share Forecast by Type (2021-2025)
12.4 Transcutaneous Neurostimulator Market Forecast by Application (2021-2025)
12.4.1 Global Transcutaneous Neurostimulator Sales Forecast by Application (2021-2025)
12.4.2 Global Transcutaneous Neurostimulator Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Transcutaneous Neurostimulator Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Transcutaneous Neurostimulator by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Transcutaneous Neurostimulator Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Medtronic Basic Information, Manufacturing Base and Competitors
Table 8. Medtronic Transcutaneous Neurostimulator Major Business
Table 9. Medtronic Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 10. Medtronic SWOT Analysis
Table 11. Medtronic Transcutaneous Neurostimulator Product and Services
Table 12. Medtronic Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. ReShape Lifesciences Basic Information, Manufacturing Base and Competitors
Table 14. ReShape Lifesciences Transcutaneous Neurostimulator Major Business
Table 15. ReShape Lifesciences Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 16. ReShape Lifesciences SWOT Analysis
Table 17. ReShape Lifesciences Transcutaneous Neurostimulator Product and Services
Table 18. ReShape Lifesciences Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Boston Scientific Corporation Transcutaneous Neurostimulator Major Business
Table 21. Boston Scientific Corporation Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 22. Boston Scientific Corporation SWOT Analysis
Table 23. Boston Scientific Corporation Transcutaneous Neurostimulator Product and Services
Table 24. Boston Scientific Corporation Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Apnex Medical Basic Information, Manufacturing Base and Competitors
Table 26. Apnex Medical Transcutaneous Neurostimulator Major Business
Table 27. Apnex Medical Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 28. Apnex Medical SWOT Analysis
Table 29. Apnex Medical Transcutaneous Neurostimulator Product and Services
Table 30. Apnex Medical Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Dynatronics Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Dynatronics Corporation Transcutaneous Neurostimulator Major Business
Table 33. Dynatronics Corporation Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 34. Dynatronics Corporation SWOT Analysis
Table 35. Dynatronics Corporation Transcutaneous Neurostimulator Product and Services
Table 36. Dynatronics Corporation Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. BioMedical Life Systems Basic Information, Manufacturing Base and Competitors
Table 38. BioMedical Life Systems Transcutaneous Neurostimulator Major Business
Table 39. BioMedical Life Systems Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 40. BioMedical Life Systems SWOT Analysis
Table 41. BioMedical Life Systems Transcutaneous Neurostimulator Product and Services
Table 42. BioMedical Life Systems Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Abbott Basic Information, Manufacturing Base and Competitors
Table 44. Abbott Transcutaneous Neurostimulator Major Business
Table 45. Abbott Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 46. Abbott SWOT Analysis
Table 47. Abbott Transcutaneous Neurostimulator Product and Services
Table 48. Abbott Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. DJO Basic Information, Manufacturing Base and Competitors
Table 50. DJO Transcutaneous Neurostimulator Major Business
Table 51. DJO Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 52. DJO SWOT Analysis
Table 53. DJO Transcutaneous Neurostimulator Product and Services
Table 54. DJO Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Cochlear LTD Basic Information, Manufacturing Base and Competitors
Table 56. Cochlear LTD Transcutaneous Neurostimulator Major Business
Table 57. Cochlear LTD Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 58. Cochlear LTD SWOT Analysis
Table 59. Cochlear LTD Transcutaneous Neurostimulator Product and Services
Table 60. Cochlear LTD Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. MED-EL Corporation Basic Information, Manufacturing Base and Competitors
Table 62. MED-EL Corporation Transcutaneous Neurostimulator Major Business
Table 63. MED-EL Corporation Transcutaneous Neurostimulator Total Revenue (USD Million) (2018-2019)
Table 64. MED-EL Corporation SWOT Analysis
Table 65. MED-EL Corporation Transcutaneous Neurostimulator Product and Services
Table 66. MED-EL Corporation Transcutaneous Neurostimulator Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Transcutaneous Neurostimulator Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Transcutaneous Neurostimulator Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Transcutaneous Neurostimulator Sales by Regions (2015-2020) (K Units)
Table 70. Global Transcutaneous Neurostimulator Sales Market Share by Regions (2015-2020)
Table 71. Global Transcutaneous Neurostimulator Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Transcutaneous Neurostimulator Sales by Countries (2015-2020) (K Units)
Table 73. North America Transcutaneous Neurostimulator Sales Market Share by Countries (2015-2020)
Table 74. North America Transcutaneous Neurostimulator Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Transcutaneous Neurostimulator Revenue Market Share by Countries (2015-2020)
Table 76. Europe Transcutaneous Neurostimulator Sales by Countries (2015-2020) (K Units)
Table 77. Europe Transcutaneous Neurostimulator Sales Market Share by Countries (2015-2020)
Table 78. Europe Transcutaneous Neurostimulator Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Transcutaneous Neurostimulator Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Transcutaneous Neurostimulator Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Transcutaneous Neurostimulator Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Transcutaneous Neurostimulator Sales by Countries (2015-2020) (K Units)
Table 83. South America Transcutaneous Neurostimulator Sales Market Share by Countries (2015-2020)
Table 84. South America Transcutaneous Neurostimulator Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Transcutaneous Neurostimulator Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Transcutaneous Neurostimulator Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Transcutaneous Neurostimulator Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Transcutaneous Neurostimulator Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Transcutaneous Neurostimulator Revenue Market Share by Countries (2015-2020)
Table 90. Global Transcutaneous Neurostimulator Sales by Type (2015-2020) (K Units)
Table 91. Global Transcutaneous Neurostimulator Sales Share by Type (2015-2020)
Table 92. Global Transcutaneous Neurostimulator Revenue by Type (2015-2020) (USD Million)
Table 93. Global Transcutaneous Neurostimulator Revenue Share by Type (2015-2020)
Table 94. Global Transcutaneous Neurostimulator Sales by Application (2015-2020) (K Units)
Table 95. Global Transcutaneous Neurostimulator Sales Share by Application (2015-2020)
Table 96. Global Transcutaneous Neurostimulator Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Transcutaneous Neurostimulator Market Share Forecast by Regions (2021-2025)
Table 98. Global Transcutaneous Neurostimulator Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Transcutaneous Neurostimulator Market Share Forecast by Type (2021-2025)
Table 100. Global Transcutaneous Neurostimulator Sales Forecast by Application (2021-2025)
Table 101. Global Transcutaneous Neurostimulator Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Transcutaneous Neurostimulator Picture
Figure 2. Global Sales Market Share of Transcutaneous Neurostimulator by Type in 2019
Figure 3. Sacral Nerves Picture
Figure 4. Vagus Nerves Picture
Figure 5. Brain Picture
Figure 6. Others Picture
Figure 7. Transcutaneous Neurostimulator Sales Market Share by Application in 2018
Figure 8. Alzheimer's Disease Picture
Figure 9. Gastroparesis Picture
Figure 10. Incontinence Picture
Figure 11. Parkinson's Disease Picture
Figure 12. Others Picture
Figure 13. Global Transcutaneous Neurostimulator Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Transcutaneous Neurostimulator Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Transcutaneous Neurostimulator Sales Market Share by Manufacturer in 2019
Figure 34. Global Transcutaneous Neurostimulator Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Transcutaneous Neurostimulator Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Transcutaneous Neurostimulator Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Transcutaneous Neurostimulator Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Transcutaneous Neurostimulator Revenue Market Share by Regions (2015-2020)
Figure 41. Global Transcutaneous Neurostimulator Revenue Market Share by Regions in 2018
Figure 42. North America Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
Figure 43. Europe Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
Figure 45. South America Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020)
Figure 47. North America Transcutaneous Neurostimulator Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Transcutaneous Neurostimulator Sales Market Share by Countries (2015-2020)
Figure 49. North America Transcutaneous Neurostimulator Sales Market Share by Countries in 2018
Figure 50. North America Transcutaneous Neurostimulator Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Transcutaneous Neurostimulator Revenue Market Share by Countries in 2018
Figure 52. United States Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Transcutaneous Neurostimulator Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Transcutaneous Neurostimulator Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Transcutaneous Neurostimulator Revenue Market Share by Countries in 2019
Figure 58. Germany Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Transcutaneous Neurostimulator Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Transcutaneous Neurostimulator Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Transcutaneous Neurostimulator Revenue Market Share by Regions 2019
Figure 66. China Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Transcutaneous Neurostimulator Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Transcutaneous Neurostimulator Sales Market Share by Countries in 2019
Figure 73. South America Transcutaneous Neurostimulator Revenue Market Share by Countries in 2019
Figure 74. Brazil Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Transcutaneous Neurostimulator Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Transcutaneous Neurostimulator Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Transcutaneous Neurostimulator Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Transcutaneous Neurostimulator Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Transcutaneous Neurostimulator Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Transcutaneous Neurostimulator Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Transcutaneous Neurostimulator Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Transcutaneous Neurostimulator Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Transcutaneous Neurostimulator Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Transcutaneous Neurostimulator Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Transcutaneous Neurostimulator Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Transcutaneous Neurostimulator Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
植込み型神経刺激装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Implantable Neurostimulator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Implantable Neuro…- 経皮モニターの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Transcutaneous Monitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Transcutaneous Monito…
- 経皮ペーシングの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Transcutaneous Pacing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Transcutaneous Pacing m…
- パーキンソン病治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Parkinson's Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Parkinson's Disease …
- ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…